Skip to content

Lifestyle Intervention for Treating Systemic Hypertension in Primary Care Setting

Lifestyle Intervention for Treating Systemic Hypertension in Primary Care Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02492035
Enrollment
60
Registered
2015-07-08
Start date
2013-02-28
Completion date
2016-12-23
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Hypertension, lifestyle, clinical trials, primary care setting

Brief summary

The Canadian hypertension education program recommends increased physical activity, adoption of the Dietary Approaches to Stop Hypertension (DASH) diet, and reduction in sodium and alcohol intake for treatment and prevention of hypertension. Objective: To describe patients participating in an interdisciplinary lifestyle intervention to reduce blood pressure in a family medicine primary care setting. Design: Descriptive study. Participants: The study aims to recruit 60 sedentary hypertensive patients to participate in a 6-month randomized-controlled trial. To be eligible, patients must be ≥18 years of age, sedentary (7-day measured steps/day and self-report), hypertensive (based on 24-h ambulatory blood pressure measurements \[ABPM\]), non-smoker, non-diabetic and without dyslipidemia. Intervention: Patients are recruited by health care professionals of the family medicine unit and are thereafter randomized to one of four intervention groups: 1) standard medical care (control), 2) improved diet (DASH diet), 3) physical activity, or 4) both improved diet and physical activity. Patients are evaluated (pre, mid and post intervention), monitored, and educated by the interdisciplinary health care team that includes a physician, a kinesiologist, a nutritionist and a nurse, depending on the intervention group. T-tests and descriptive statistics were used to analyse data. This study will document the efficacy of a primary care lifestyle intervention program on cardiometabolic and hypertension risk factors.

Interventions

BEHAVIORALLifestyle intervention

Sponsors

Fondation IUCPQ
CollaboratorOTHER
CSSS-VC
CollaboratorUNKNOWN
GMF-UMF Laval-Québec
CollaboratorUNKNOWN
Laval University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* ≥18 years of age * Sedentary (7-day measured steps/day and self-report) * Arterial hypertensive (based on 24-h ambulatory blood pressure measurements \[ABPM\])

Exclusion criteria

* secondary hypertension * diabetes * dyslipidemia * cardiovascular diseases with complications * smoker

Design outcomes

Primary

MeasureTime frame
Systolic and diastolic blood pressure6 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026